What is LeBauer Allergy?
LeBauer Allergy & Asthma operates as a premier medical practice providing comprehensive allergy, asthma, and sinus care services across Greensboro and Burlington, NC. The firm distinguishes itself through a patient-centered approach, utilizing board-certified physicians to deliver advanced treatments including immunotherapy and allergy shots. By focusing on personalized care plans for seasonal, food, and skin allergies, the company has established a strong market presence as a trusted provider of chronic condition management. Their commitment to high-quality clinical outcomes positions them as a leader in regional specialized healthcare, effectively bridging the gap between complex medical diagnostics and accessible patient support.
How much funding has LeBauer Allergy raised?
LeBauer Allergy has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in LeBauer Allergy
PPP
Public-Private Partnership
What's next for LeBauer Allergy?
With the infusion of this latest capital, LeBauer Allergy is well-positioned to scale its service delivery model and enhance its technological infrastructure for patient management. The strategic focus will likely shift toward optimizing clinical workflows and expanding the reach of their immunotherapy programs to address the growing demand for specialized allergy care. As the practice matures, the integration of data-driven treatment protocols will be essential in maintaining their competitive advantage. Future initiatives may include the adoption of advanced diagnostic tools and the potential expansion of their physical footprint to serve a broader demographic, ensuring that the organization remains at the forefront of allergy and asthma treatment innovation.
See full LeBauer Allergy company page
